Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer

Condition:   Breast Cancer Interventions:   Drug: EG12014;   Drug: Herceptin Sponsor:   EirGenix, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials